Viking Therapeutics Inc.

VKTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$30.11

+$1.12 (+3.86%)

At close: Sep 21, 2026, 4:00 PM ET

$31.90

+$1.79 (+5.94%)

Pre-market: Sep 22, 2026, 4:49 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.38B

Enterprise Value $3.01B

Beta 0.68

Average Volume 2.22M

Shares Outstanding (Diluted) 115.92M

Shares Change YoY 3.37%

Institutional Ownership 63.45%

Exchange NASDAQ

ISIN US92686J1060

Price Performance

Price Change 1M -10.8%

Price Change 3M -13.5%

Price Change 6M -9.3%

Price Change YTD -15.0%

Price Change 1Y 14.7%

Price Change 3Y 133.8%

Price Change 5Y 364.7%

1M CAGR (ann.) -12.9%

1Y CAGR (ann.) 25.6%

5Y CAGR (ann.) 34.4%

All-Time CAGR 12.0%

Valuation

PE Ratio -6.46

Forward PE N/A

PEG Ratio 0.08

Forward PEG 1.30

PS Ratio N/A

Forward PS 477.90

PB Ratio 8.60

P/FCF Ratio -8.39

P/Adj. FCF Ratio -7.71

P/OCF Ratio -8.34

EV/Sales N/A

EV/EBIT -5.64

EV/EBITDA -5.64

EV/FCF -7.20

Earnings Yield -15.5%

FCF Yield -11.9%

Adj. FCF Yield -13.0%

Financial Health

Net Cash $501.66M

Total Debt $4.09M

Cash & Short-Term Investments $501.66M

Total Assets $521.9M

Current Ratio 4.72

Quick Ratio 4.72

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -102.41

Interest Coverage -70,002.63

Altman Z-Score 12.38

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.9%

Returns

Return on Assets -102.5%

Return on Equity -94.6%

Return on Invested Capital -135.8%

Return on Capital Employed -135.8%

Return on Tangible Assets -102.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -78.3%

EPS CAGR 5Y -48.0%

EPS CAGR 10Y -23.7%

FCF CAGR 3Y -80.8%

FCF CAGR 5Y -55.6%

FCF CAGR 10Y -35.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 24

EPS Growth Next 3Y 23.1%

Revenue Growth Next 3Y N/A

Earnings Date Oct 27, 2026

EPS Estimate (next Q) -$1.07

EPS Growth Est (next Q) 31.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $91.75

Price Target Upside 204.7%

Cash Flow

Operating Cash Flow $-418.44M

Free Cash Flow $-418.44M

Adj. Free Cash Flow $-455.83M

FCF Per Share -$3.61

OCF Per Share -$3.61

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-208K

Operating Income $-560.02M

EBITDA $-534.42M

Net Income $-534.8M

EPS (Diluted) -$4.66

Revenue / Employee N/A

Profit / Employee $-8.23M

Employees 65